人类绒毛膜性腺激素(HCG)的全球市场:2022年~2026年
市场调查报告书
商品编码
1105022

人类绒毛膜性腺激素(HCG)的全球市场:2022年~2026年

Global Human Chorionic Gonadotropin (HCG) Market 2022-2026

出版日期: | 出版商: TechNavio | 英文 120 Pages | 订单完成后即时交付

价格

全球人类绒毛膜性腺激素(HCG)的市场规模在2022年~2026年间,预测将成长到3亿349万美元,在预测期间内预计将以年复合成长率6.7%成长。

市场成长的主要因素有不孕症的增加,体外受精的需求提升,临床用途的扩大。

本报告提供全球人类绒毛膜性腺激素(HCG)市场相关调查分析,提供市场规模与预测,趋势,成长促进因素,课题,再加上约25家供应商的供应商分析等资讯。

目录

第1章 摘要整理

  • 市场概要

第2章 市场形势

  • 市场生态系统

第3章 市场规模

  • 市场定义
  • 市场区隔分析
  • 市场规模:2021年
  • 市场预测:2021年~2026年的预测

第4章 波特的五力分析

  • 五力的摘要
  • 买方议价能力
  • 供应商谈判力
  • 新兴企业的威胁
  • 替代品的威胁
  • 竞争企业的威胁
  • 市场情况

第5章 市场区隔:各技术

  • 市场区隔
  • 比较:各技术
  • 天然开采 - 市场规模与预测:2021年~2026年
  • 基因重组技术 - 市场规模与预测:2021年~2026年
  • 市场机会:各技术

第6章 客户形势

  • 客户形势概要

第7章 各地区形势

  • 各地区市场区隔
  • 各地区比较
  • 北美 - 市场规模与预测:2021年~2026年
  • 欧洲 - 市场规模与预测:2021年~2026年
  • 亚洲 - 市场规模与预测:2021年~2026年
  • 其他地区(ROW) - 市场规模与预测:2021年~2026年
  • 美国 - 市场规模与预测:2021年~2026年
  • 德国 - 市场规模与预测:2021年~2026年
  • 中国 - 市场规模与预测:2021年~2026年
  • 英国 - 市场规模与预测:2021年~2026年
  • 加拿大 - 市场规模与预测:2021年~2026年
  • 市场机会:各地区形势

第8章 促进因素,课题,及趋势

  • 推动市场要素
  • 市场课题
  • 推动因素与课题的影响
  • 市场趋势

第9章 业者情势

  • 概要
  • 业者情势
  • 混乱状况
  • 产业的风险

第10章 供应商分析

  • 交易厂商
  • 供应商的市场定位
  • Cigna Corp.
  • Ferring B.V.
  • Fresenius Kabi AG
  • Intas Pharmaceuticals Ltd.
  • Lee BioSolutions Inc
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Sanzyme P Ltd.
  • Scripps Laboratories Inc.
  • Sun Pharmaceutical Industries Ltd.

第11章 附录

Product Code: IRTNTR73910

Technavio has been monitoring the human chorionic gonadotropin (HCG) market and it is poised to grow by $ 303.49 mn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. Our report on the human chorionic gonadotropin (HCG) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the prevalence of infertility, rising demand for IVF, and rising clinical application.

The human chorionic gonadotropin (HCG) market analysis includes technology segment and geographic landscape.

Technavio's human chorionic gonadotropin (HCG) market is segmented as below:

By Technology

  • Natural source extraction
  • Recombinant technology

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the emerging trend of delayed pregnancies among women as one of the prime reasons driving the human chorionic gonadotropin (HCG) market growth during the next few years. Also, advancements in recombinant technology and innovative technologies to measure the level of HCG will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the human chorionic gonadotropin (HCG) market covers the following areas:

  • Human chorionic gonadotropin (HCG) market sizing
  • Human chorionic gonadotropin (HCG) market forecast
  • Human chorionic gonadotropin (HCG) market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human chorionic gonadotropin (HCG) market vendors that include Biocare Medical LLC, Cigna Corp., Cipla Ltd., Ferring B.V., Fresenius Kabi AG, Intas Pharmaceuticals Ltd., Kamia Biomedical Company, Lee BioSolutions Inc, Lupin Ltd., Merck and Co. Inc., MyBioSource Inc., Prospec Tany Technogene Ltd., Sanzyme P Ltd., Scripps Laboratories Inc., and Sun Pharmaceutical Industries Ltd. Also, the human chorionic gonadotropin (HCG) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Technology

  • 5.1 Market segments
  • Exhibit 24: Chart on Technology - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Technology - Market share 2021-2026 (%)
  • 5.2 Comparison by Technology
  • Exhibit 26: Chart on Comparison by Technology
  • Exhibit 27: Data Table on Comparison by Technology
  • 5.3 Natural source extraction - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Natural source extraction - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Natural source extraction - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Natural source extraction - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Natural source extraction - Year-over-year growth 2021-2026 (%)
  • 5.4 Recombinant technology - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Recombinant technology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Recombinant technology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Recombinant technology - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Recombinant technology - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Technology
  • Exhibit 36: Market opportunity by Technology ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 China - Market size and forecast 2021-2026
  • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.10 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Cigna Corp.
  • Exhibit 85: Cigna Corp. - Overview
  • Exhibit 86: Cigna Corp. - Product / Service
  • Exhibit 87: Cigna Corp. - Key offerings
  • 10.4 Ferring B.V.
  • Exhibit 88: Ferring B.V. - Overview
  • Exhibit 89: Ferring B.V. - Product / Service
  • Exhibit 90: Ferring B.V. - Key offerings
  • 10.5 Fresenius Kabi AG
  • Exhibit 91: Fresenius Kabi AG - Overview
  • Exhibit 92: Fresenius Kabi AG - Business segments
  • Exhibit 93: Fresenius Kabi AG - Key news
  • Exhibit 94: Fresenius Kabi AG - Key offerings
  • Exhibit 95: Fresenius Kabi AG - Segment focus
  • 10.6 Intas Pharmaceuticals Ltd.
  • Exhibit 96: Intas Pharmaceuticals Ltd. - Overview
  • Exhibit 97: Intas Pharmaceuticals Ltd. - Product / Service
  • Exhibit 98: Intas Pharmaceuticals Ltd. - Key offerings
  • 10.7 Lee BioSolutions Inc
  • Exhibit 99: Lee BioSolutions Inc - Overview
  • Exhibit 100: Lee BioSolutions Inc - Product / Service
  • Exhibit 101: Lee BioSolutions Inc - Key offerings
  • 10.8 Lupin Ltd.
  • Exhibit 102: Lupin Ltd. - Overview
  • Exhibit 103: Lupin Ltd. - Product / Service
  • Exhibit 104: Lupin Ltd. - Key news
  • Exhibit 105: Lupin Ltd. - Key offerings
  • 10.9 Merck and Co. Inc.
  • Exhibit 106: Merck and Co. Inc. - Overview
  • Exhibit 107: Merck and Co. Inc. - Business segments
  • Exhibit 108: Merck and Co. Inc. - Key news
  • Exhibit 109: Merck and Co. Inc. - Key offerings
  • Exhibit 110: Merck and Co. Inc. - Segment focus
  • 10.10 Sanzyme P Ltd.
  • Exhibit 111: Sanzyme P Ltd. - Overview
  • Exhibit 112: Sanzyme P Ltd. - Product / Service
  • Exhibit 113: Sanzyme P Ltd. - Key offerings
  • 10.11 Scripps Laboratories Inc.
  • Exhibit 114: Scripps Laboratories Inc. - Overview
  • Exhibit 115: Scripps Laboratories Inc. - Product / Service
  • Exhibit 116: Scripps Laboratories Inc. - Key offerings
  • 10.12 Sun Pharmaceutical Industries Ltd.
  • Exhibit 117: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibit 118: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibit 119: Sun Pharmaceutical Industries Ltd. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 120: Inclusions checklist
  • Exhibit 121: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 122: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 123: Research methodology
  • Exhibit 124: Validation techniques employed for market sizing
  • Exhibit 125: Information sources
  • 11.5 List of abbreviations
  • Exhibit 126: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Technology - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Technology - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Technology
  • Exhibits27: Data Table on Comparison by Technology
  • Exhibits28: Chart on Natural source extraction - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Natural source extraction - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Natural source extraction - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Natural source extraction - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Recombinant technology - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Recombinant technology - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Recombinant technology - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Recombinant technology - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Technology ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: Cigna Corp. - Overview
  • Exhibits86: Cigna Corp. - Product / Service
  • Exhibits87: Cigna Corp. - Key offerings
  • Exhibits88: Ferring B.V. - Overview
  • Exhibits89: Ferring B.V. - Product / Service
  • Exhibits90: Ferring B.V. - Key offerings
  • Exhibits91: Fresenius Kabi AG - Overview
  • Exhibits92: Fresenius Kabi AG - Business segments
  • Exhibits93: Fresenius Kabi AG - Key news
  • Exhibits94: Fresenius Kabi AG - Key offerings
  • Exhibits95: Fresenius Kabi AG - Segment focus
  • Exhibits96: Intas Pharmaceuticals Ltd. - Overview
  • Exhibits97: Intas Pharmaceuticals Ltd. - Product / Service
  • Exhibits98: Intas Pharmaceuticals Ltd. - Key offerings
  • Exhibits99: Lee BioSolutions Inc - Overview
  • Exhibits100: Lee BioSolutions Inc - Product / Service
  • Exhibits101: Lee BioSolutions Inc - Key offerings
  • Exhibits102: Lupin Ltd. - Overview
  • Exhibits103: Lupin Ltd. - Product / Service
  • Exhibits104: Lupin Ltd. - Key news
  • Exhibits105: Lupin Ltd. - Key offerings
  • Exhibits106: Merck and Co. Inc. - Overview
  • Exhibits107: Merck and Co. Inc. - Business segments
  • Exhibits108: Merck and Co. Inc. - Key news
  • Exhibits109: Merck and Co. Inc. - Key offerings
  • Exhibits110: Merck and Co. Inc. - Segment focus
  • Exhibits111: Sanzyme P Ltd. - Overview
  • Exhibits112: Sanzyme P Ltd. - Product / Service
  • Exhibits113: Sanzyme P Ltd. - Key offerings
  • Exhibits114: Scripps Laboratories Inc. - Overview
  • Exhibits115: Scripps Laboratories Inc. - Product / Service
  • Exhibits116: Scripps Laboratories Inc. - Key offerings
  • Exhibits117: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibits118: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibits119: Sun Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits120: Inclusions checklist
  • Exhibits121: Exclusions checklist
  • Exhibits122: Currency conversion rates for US$
  • Exhibits123: Research methodology
  • Exhibits124: Validation techniques employed for market sizing
  • Exhibits125: Information sources
  • Exhibits126: List of abbreviations